Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions.
Journal
Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252
Informations de publication
Date de publication:
09 11 2020
09 11 2020
Historique:
entrez:
23
11
2020
pubmed:
24
11
2020
medline:
29
12
2020
Statut:
epublish
Résumé
In Alzheimer's disease (AD) and other neurodegenerative disorders, oligodendroglial failure is a common early pathological feature, but how it contributes to disease development and progression, particularly in the gray matter of the brain, remains largely unknown. The dysfunction of oligodendrocyte lineage cells is hallmarked by deficiencies in myelination and impaired self-renewal of oligodendrocyte precursor cells (OPCs). These two defects are caused at least in part by the disruption of interactions between neuron and oligodendrocytes along the buildup of pathology. OPCs give rise to myelinating oligodendrocytes during CNS development. In the mature brain cortex, OPCs are the major proliferative cells (comprising ~5% of total brain cells) and control new myelin formation in a neural activity-dependent manner. Such neuron-to-oligodendrocyte communications are significantly understudied, especially in the context of neurodegenerative conditions such as AD, due to the lack of appropriate tools. In recent years, our group and others have made significant progress to improve currently available protocols to generate functional neurons and oligodendrocytes individually from human pluripotent stem cells. In this manuscript, we describe our optimized procedures, including the establishment of a co-culture system to model the neuron-oligodendrocyte connections. Our illustrative results suggest an unexpected contribution from OPCs/oligodendrocytes to the brain amyloidosis and synapse integrity and highlight the utility of this methodology for AD research. This reductionist approach is a powerful tool to dissect the specific hetero-cellular interactions out of the inherent complexity inside the brain. The protocols we describe here are expected to facilitate future studies on oligodendroglial defects in the pathogenesis of neurodegeneration.
Identifiants
pubmed: 33226027
doi: 10.3791/61778
pmc: PMC7739515
mid: NIHMS1644449
doi:
Substances chimiques
Dimethyl Sulfoxide
YOW8V9698H
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Video-Audio Media
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIA NIH HHS
ID : R00 AG054616
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM136566
Pays : United States
Commentaires et corrections
Type : ErratumIn
Références
PLoS One. 2017 Feb 13;12(2):e0171947
pubmed: 28192470
Neurosci Lett. 2020 May 14;727:134916
pubmed: 32194135
Nat Neurosci. 2019 Dec;22(12):2087-2097
pubmed: 31768052
Cell Stem Cell. 2015 Feb 5;16(2):198-210
pubmed: 25658373
Neuron. 2016 Jan 6;89(1):37-53
pubmed: 26687838
Proc Natl Acad Sci U S A. 2017 Mar 14;114(11):E2243-E2252
pubmed: 28246330
Cell. 2019 Oct 3;179(2):498-513.e22
pubmed: 31585084
Exp Mol Med. 2017 Jul 28;49(7):e361
pubmed: 28751784
J Comp Neurol. 2014 Aug 15;522(12):2877-86
pubmed: 24771471
Neuron. 2018 Jun 27;98(6):1294
pubmed: 29953873
Development. 2009 May;136(9):1443-52
pubmed: 19363151
J Neurosci. 2005 May 11;25(19):4694-705
pubmed: 15888645
Mol Psychiatry. 2020 Jan;25(1):148-167
pubmed: 31391546
Stem Cell Reports. 2014 Aug 12;3(2):250-9
pubmed: 25254339
Nat Methods. 2013 Jun;10(6):553-6
pubmed: 23584186
Stem Cell Reports. 2017 Jun 6;8(6):1770-1783
pubmed: 28552605
Glia. 2013 Feb;61(2):273-86
pubmed: 23090919
J Neurosci. 2019 Sep 11;39(37):7408-7427
pubmed: 31331998
Neuron. 2013 Jun 5;78(5):785-98
pubmed: 23764284
Neuron. 2008 Nov 6;60(3):430-40
pubmed: 18995817
Cell Stem Cell. 2013 Feb 7;12(2):252-64
pubmed: 23395447
Annu Rev Neurosci. 2018 Jul 8;41:61-76
pubmed: 29986163
Nat Med. 2014 Aug;20(8):954-960
pubmed: 24997607
Nat Neurosci. 2018 May;21(5):696-706
pubmed: 29556025
Science. 2014 May 2;344(6183):1252304
pubmed: 24727982
Neurobiol Dis. 2019 Oct;130:104503
pubmed: 31202913
PLoS One. 2018 Dec 12;13(12):e0208110
pubmed: 30540809
Biomol Ther (Seoul). 2017 Jul 1;25(4):362-366
pubmed: 28605832
Neurobiol Aging. 2008 Nov;29(11):1754-62
pubmed: 17544173
Nat Neurosci. 2020 Apr;23(4):487-499
pubmed: 32042175
Cell. 2016 Feb 11;164(4):603-15
pubmed: 26871627
Nat Protoc. 2015 Aug;10(8):1143-54
pubmed: 26134954
Development. 2015 Dec 1;142(23):3983-95
pubmed: 26628089
Nat Biotechnol. 2013 May;31(5):434-9
pubmed: 23584610
Mol Neurobiol. 2016 Jul;53(5):3046-3062
pubmed: 25966971
J Vis Exp. 2019 Jul 17;(149):
pubmed: 31380840
Cell. 2017 Jan 26;168(3):427-441.e21
pubmed: 28111074
Cell Stem Cell. 2018 Aug 02;23(2):239-251.e6
pubmed: 30075130
Nat Methods. 2018 Sep;15(9):700-706
pubmed: 30046099
Glia. 2020 Apr;68(4):705-720
pubmed: 31633852
Mol Cell Neurosci. 2007 Mar;34(3):310-23
pubmed: 17196394